ZHEJIANG XIANJU PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.63 CNY | +1.77% |
|
+2.68% | -1.10% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 4.73B 655M | Sales 2025 * | 5.56B 770M | Capitalization | 12.49B 1.73B |
|---|---|---|---|---|---|
| Net income 2024 * | 679M 94.01M | Net income 2025 * | 875M 121M | EV / Sales 2024 * | 2.64 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.25 x |
| P/E ratio 2024 * |
18.4
x | P/E ratio 2025 * |
14.3
x | Employees | 3,281 |
| Yield 2024 * |
1.9% | Yield 2025 * |
2.3% | Free-Float | 75.95% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.77% | ||
| 1 week | +2.68% | ||
| Current month | +7.49% | ||
| 1 month | +19.94% | ||
| 3 months | +20.86% | ||
| 6 months | +4.29% | ||
| Current year | -1.10% |
1 week
12.15
13.04
1 month
10.4013.04
Current year
8.4413.05
1 year
8.4415.80
3 years
7.9515.80
5 years
6.0118.93
10 years
5.0319.90
| Managers | Title | Age | Since |
|---|---|---|---|
Yao Hua Wang
DFI | Director of Finance/CFO | 53 | 13-05-14 |
Yu Song Zhang
CHM | Chairman | 54 | 07-12-20 |
Wang Wei Zhang
BRD | Director/Board Member | 42 | 16-12-25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yun Hong Hao
BRD | Director/Board Member | 61 | 21-05-18 |
Yu Song Zhang
CHM | Chairman | 54 | 07-12-20 |
Wei Wu Chen
BRD | Director/Board Member | 53 | 10-12-20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 112 M€ | +5.41% | - | |
| 0.00% | 34 M€ | +3.87% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 12.63 | +1.77% | 12,479,980 |
| 24-05-16 | 12.41 | -3.27% | 17,476,450 |
| 24-05-15 | 12.83 | +4.48% | 28,323,670 |
| 24-05-14 | 12.28 | +0.49% | 10,345,820 |
| 24-05-13 | 12.22 | -0.65% | 10,979,900 |
End-of-day quote Shenzhen S.E., May 16, 2024
More quotes
ZHEJIANG XIANJU PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the research, manufacture and distribution of steroid active pharmaceutical ingredients (APIs) and preparations. The Company's products are mainly categorized into cortex hormone drugs, gynecology and family planning drugs, as well as anesthesia drugs and muscle relaxants. The Company is also involved in the provision of respiratory drugs, immunomodulators, dermatology drugs, anaesthetic drugs and others. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
12.63
CNY
Average target price
16.21
CNY
Spread / Average Target
+28.35%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -1.10% | 1.7B | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
- Stock Market
- Equities
- 002332 Stock